• Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study (MMAPPS)
Are you a healthy adult without psoriasis?

Subjects age 18-80 who do not have psoriasis may be eligible to participate as control subjects in a research study investigating the degree of inflamed coronary artery and aortic atherosclerotic plaque by cardiac FDG-PET in subjects with or without psoriasis. Participation in this study requires an initial screen visit to determine eligibility, followed by 2 outpatient visits over approximately 1 month for eligible subjects. Compensation up to $125 is provided. For more information call Allison Han at (617) 724-0248, Program in Nutritional Metabolism, Massachusetts General Hospital.
Institution  –  MGH - Massachusetts General Hospital, Boston, MA; Massachusetts General Hospital, Boston, MA
Principal Investigator  – Steven Grinspoon, MD
  
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name  – Allison Han
Email  – amhan@partners.org
Phone  – 617-724-0248